|
|
|
| December 21, 2005 |
FSMA and Invitrogen Partner to Investigate Molecular Mechanisms of SMA
Invitrogen Corporation and FSMA today announced a new collaboration to identify biological targets that are linked to the causes and symptoms of (SMA).
|
|
|
| June 20, 2005 |
Research Question & Answer Session from 2005 Family Conference
A transcript of the Research Q&A Session that included Drs. Jill Jarecki, Arthur Burghes, Douglas Kerr, and Kathryn Swoboda
|
|
|
| June 17, 2005 |
Research Update Slide Show 2005 Family Conference
Update on FSMA Research Activities by Jill Jarecki, FSMA Research Director
|
|
|
| May 12, 2005 |
Clinical Trials Chat Part II
Clinical Trials Chat Part II with Dr. Sandra Reyna and Dr. Kathryn Swoboda
|
|
|
| May 11, 2005 |
Clinical Trials Chat Part I
Clinical Trials Chat Part I with Dr. Sandra Reyna and Dr. Kathryn Swoboda
|
|
|
| May 3, 2005 |
SMA CARNI-VAL TRIAL ANNOUNCED
Project Cure SMA and FSMA are pleased to announce a multi-center phase II clinical trial to further evaluate a combined regimen of valproic acid and carnitine in children with Spinal Muscular Atrophy (SMA).
|
|
|
| April 30, 2005 |
Project Cure SMA Publishes Paper in "Annals of Neurology"
Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function, by Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, Bromberg MB.
|
|
|
| February 8, 2005 |
Families of SMA Welcomes New Research Director
Dr. Jill Jarecki will serve as the coordinator of Families of SMA’s extensive research programs including the drug discovery efforts with deCODE Genetics and the drug testing program through Project Cure SMA. She will also serve as a liaison with the many recipients of FSMA’s Scientific Research Grants.
|
|
|
|
|
|
